Lapatinib Terminated Phase 1 Trials for Cancer, Ovarian Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00317434Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer